540 related articles for article (PubMed ID: 18049474)
21. Clinical management of HIV/hepatitis C virus coinfection.
Pozza R
J Am Acad Nurse Pract; 2008 Oct; 20(10):496-505. PubMed ID: 19128345
[TBL] [Abstract][Full Text] [Related]
22. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
[TBL] [Abstract][Full Text] [Related]
23. [The hepatitis C virus: after the track of the human immunodeficiency virus].
Pérez-Olmeda M; Rodríguez-Rosado R; García-Samaniego J; Soriano V
Rev Clin Esp; 1999 Jan; 199(1):5-7. PubMed ID: 10089769
[No Abstract] [Full Text] [Related]
24. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
25. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
Fernández I; Muñoz R; Solís-Herruzo JA
Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
[No Abstract] [Full Text] [Related]
26. [Management of HCV-HIV patients].
Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
[TBL] [Abstract][Full Text] [Related]
27. Management of HIV: a swing back to the future.
Alozie OK; Bonham S; Henry WK
Minn Med; 2009 Oct; 92(10):45-9. PubMed ID: 19916274
[TBL] [Abstract][Full Text] [Related]
28. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
Durantel D; Alotte C; Zoulim F
Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
[TBL] [Abstract][Full Text] [Related]
29. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
Corales RB; Djeloski DS; Mancenido MD; Valenti WM
AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
[No Abstract] [Full Text] [Related]
30. Viral hepatitis and HIV coinfection.
Sulkowski MS
J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
[TBL] [Abstract][Full Text] [Related]
31. Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic.
AIDS Alert; 2006 Aug; 21(8):85-7. PubMed ID: 16913040
[No Abstract] [Full Text] [Related]
32. Antiretroviral drug development for HIV: challenges for the future.
Boone LR; Koszalka GW
Curr Opin Investig Drugs; 2010 Aug; 11(8):863-67. PubMed ID: 21072979
[TBL] [Abstract][Full Text] [Related]
33. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
34. Resistance mechanisms in HCV: from evolution to intervention.
Kim AY; Timm J
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):463-78. PubMed ID: 18662114
[TBL] [Abstract][Full Text] [Related]
35. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.
De Clercq E
Adv Virus Res; 2009; 73():1-53. PubMed ID: 19695380
[TBL] [Abstract][Full Text] [Related]
36. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J
Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767
[TBL] [Abstract][Full Text] [Related]
37. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
38. Treatment and vaccination for hepatitis C: present and future.
Jawaid A; Khuwaja AK
J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
[TBL] [Abstract][Full Text] [Related]
39. Estimating drug efficacy and viral dynamic parameters: HIV and HCV.
Perelson AS; Ribeiro RM
Stat Med; 2008 Oct; 27(23):4647-57. PubMed ID: 17960579
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias.
Stasi R
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S15-25. PubMed ID: 19245929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
